Back to GetFilings.com



Table of Contents

SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 10-Q

(Mark One)

x

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

 

 

For the quarterly period ended     March 31, 2003

 

 

 

OR

 

 

 

o

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

 

 

For the transition period from ___________________ to___________________

 

Commission file number 0-16752

 

MEDSTONE INTERNATIONAL, INC.


(Exact name of registrant as specified in its charter)

 

 

 

DELAWARE

 

66-0439440


 


(State or other jurisdiction of incorporation or organization)

 

(I.R.S. Employer Identification No.)

 

 

 

100 Columbia, Suite 100, Aliso Viejo, California

 

92656


 


(Address of principal executive offices)

 

(Zip code)

 

 

 

Registrant’s telephone number, including area code:     (949) 448-7700

 

Not Applicable


(Former name, former address and former fiscal year, if changed, since last report)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days.

Yes   x

No   o

The number of shares of the Common Stock of the registrant outstanding as of May 1, 2003 was 3,758,220

Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Act).

Yes   o

No   x

The number of shares of the Common Stock of the registrant outstanding as of June 30, 2002 was 3,920,020. The number of shares voting and non-voting Common Stock held by non-affiliates on such date was 3,827,312 with an approximate aggregate market value of $19,327,926.


Table of Contents

MEDSTONE INTERNATIONAL, INC.

INDEX TO FORM 10-Q

 

 

Page No.

 

 


PART I.     FINANCIAL INFORMATION

 

 

 

 

Item 1.

Financial Statements:

 

 

 

 

 

Consolidated Balance Sheets March 31, 2003 (Unaudited) and December 31, 2002

3

 

 

 

 

Consolidated Statements of Income Three Months Ended March 31, 2003 and 2002 (Unaudited)

4

 

 

 

 

Consolidated Statement of Stockholders’ Equity Three Months Ended March 31, 2003 (Unaudited)

5

 

 

 

 

Consolidated Statements of Cash Flows Three Months Ended March 31, 2003 and 2002 (Unaudited)

6

 

 

 

 

Notes to Unaudited Consolidated Financial Statements

7

 

 

 

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

11

     
Item 3. Market Risk Changes  
     

 Item 4.

Controls and Procedures

 

   

PART II.     OTHER INFORMATION

 

 

 

 

Item 1.

Legal Proceedings

15

 

 

 

Item 2.

Changes in Securities

15

 

 

 

Item 3.

Defaults Upon Senior Securities

15

 

 

 

Item 4.

Submission of Matters to a Vote of Security Holders

15

 

 

 

Item 5.

Other Information

15

 

 

 

Item 6.

Exhibits and Reports on Form 8-K

15

 

 

 

Signatures

16

 

 

Certifications

 

- 2 -

Table of Contents

MEDSTONE INTERNATIONAL, INC.
CONSOLIDATED BALANCE SHEETS

 

 

March 31,
2003

 

December 31,
2002

 

 

 


 


 

 

 

 

 

(Unaudited)

 

ASSETS

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

1,940,332

 

$

2,050,466

 

Short-term investments held to maturity

 

 

4,341,831

 

 

4,323,491

 

Accounts receivable, less allowance for doubtful accounts of $931,769 and $871,769 at March 31, 2003 and December 31, 2002, respectively

 

 

3,289,013

 

 

3,720,410

 

Income taxes receivable

 

 

589,375

 

 

589,375

 

Inventories, less allowance for inventory obsolescence of $716,700 and $642,712 at March 31, 2003 and December 31, 2002, respectively

 

 

6,405,923

 

 

6,440,304

 

Deferred tax assets

 

 

955,877

 

 

955,877

 

Prepaid expenses and other current assets

 

 

1,007,585

 

 

647,169

 

 

 



 



 

Total current assets

 

 

18,529,936

 

 

18,727,092

 

 

 



 



 

Buildings, property and equipment, at cost:

 

 

 

 

 

 

 

Building

 

 

359,324

 

 

359,324

 

Lithotripters

 

 

13,750,702

 

 

13,524,440

 

Equipment, furniture and fixtures

 

 

3,387,807

 

 

3,368,431

 

Leasehold improvements

 

 

177,318

 

 

177,318

 

 

 



 



 

 

 

 

17,675,151

 

 

17,429,513

 

Less accumulated depreciation and amortization

 

 

(13,989,559

)

 

(13,602,049

)

 

 



 



 

Net property and equipment

 

 

3,685,592

 

 

3,827,464

 

 

 



 



 

Goodwill, net

 

 

2,929,897

 

 

2,929,897

 

Investment in unconsolidated subsidiaries

 

 

794,744

 

 

734,083

 

Net investment in sale-type lease

 

 

119,514

 

 

169,428

 

Other assets, net

 

 

86,964

 

 

93,243

 

 

 



 



 

 

 

$

26,146,647

 

$

26,481,207

 

 

 



 



 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

Accounts payable

 

$

715,166

 

$

900,295

 

Accrued expenses

 

 

311,168

 

 

267,229

 

Accrued payroll expenses

 

 

344,302

 

 

366,855

 

Customer deposits

 

 

120,187

 

 

75,175

 

Deferred revenue

 

 

469,581

 

 

494,704

 

 

 



 



 

Total current liabilities

 

 

1,960,404

 

 

2,104,258

 

 

 



 



 

Deferred tax liabilities

 

 

639,224

 

 

639,224

 

Minority interest

 

 

395,606

 

 

423,224

 

Deferred rent

 

 

79,135

 

 

82,613

 

Commitments and contingencies (Notes 7 and 8)

 

 

—  

 

 

—  

 

Stockholders’ equity:

 

 

 

 

 

 

 

Common stock - $.004 par value, 20,000,000 shares authorized, 5,742,670 shares issued at both March 31, 2003 and December 31, 2002

 

 

22,971

 

 

22,971

 

Additional paid-in capital

 

 

19,646,388

 

 

19,646,388

 

Accumulated earnings

 

 

16,228,627

 

 

16,350,292

 

Accumulated other comprehensive loss

 

 

(59,999

)

 

(22,054

)

Treasury stock,  at cost, 1,984,450 at both March 31, 2003 and December 31, 2002, respectively

 

 

(12,765,709

)

 

(12,765,709

)

 

 



 



 

Total stockholders’ equity

 

 

23,072,278

 

 

23,231,888

 

 

 



 



 

 

 

$

26,146,647

 

$

26,481,207

 

 

 



 



 

See accompanying notes

- 3 -

Table of Contents

MEDSTONE INTERNATIONAL, INC.
CONSOLIDATED STATEMENTS OF INCOME
Three months ended March 31, 2003 and 2002
(Unaudited)

 

 

2003

 

2002

 

 

 


 


 

Revenues:

 

 

 

 

 

 

 

Procedures, maintenance fees and fee-for-service

 

$

4,068,423

 

$

4,337,435

 

Net equipment sales

 

 

719,127

 

 

1,896,443

 

Interest income

 

 

40,501

 

 

82,123

 

 

 



 



 

Total revenues

 

 

4,828,051

 

 

6,316,001

 

Costs and operating expenses:

 

 

 

 

 

 

 

Cost of procedures and maintenance fees

 

 

2,231,259

 

 

2,426,949

 

Cost of equipment sales

 

 

795,404

 

 

1,474,909

 

Research and development

 

 

409,061

 

 

260,939

 

Selling

 

 

617,033

 

 

812,215

 

General and administrative

 

 

802,119

 

 

817,490

 

 

 



 



 

Total costs and operating expenses

 

 

4,854,876

 

 

5,792,502

 

 

 



 



 

Operating income (loss)

 

 

(26,825

)

 

523,499

 

Other expense (income)

 

 

23,820

 

 

(1,887

)

Minority interests:

 

 

 

 

 

 

 

Minority interest in subsidiaries income

 

 

170,381

 

 

170,019

 

Equity in loss (income) from unconsolidated subsidiary

 

 

(69,161

)

 

30,359

 

 

 



 



 

Total minority interest

 

 

101,220

 

 

200,378

 

 

 



 



 

Income (loss) before provision for income taxes

 

 

(151,865

)

 

325,008

 

Provision for (benefit from) income taxes

 

 

(30,200

)

 

157,800

 

 

 



 



 

Net income (loss)

 

$

(121,665

)

$

167,208

 

 

 



 



 

Net income (loss) per share:

 

 

 

 

 

 

 

Basic

 

$

(.03

)

$

.04

 

 

 



 



 

Diluted

 

 

N/A

 

$

.04

 

 

 



 



 

Number of shares used in the computation of earnings (loss) per share:

 

 

 

 

 

 

 

Basic

 

 

3,758,220

 

 

3,954,553

 

 

 



 



 

Diluted

 

 

N/A

 

 

3,954,553

 

 

 



 



 

See accompanying notes.

- 4 -

Table of Contents

MEDSTONE INTERNATIONAL, INC.
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

 

 

Common Stock

 

 

Additional
paid-in
capital

 

Accumulated
earnings

 

Accumulated
Other
Comprehensive
loss

 

Treasury
Stock

 

Total

 


Number of
shares

 

Amount

 

 



 



 



 



 



 



 



 

Balance at December 31, 2002

 

 

3,758,220

 

$

22,971

 

$

19,646,388

 

$

16,350,292

 

$

(22,054

)

$

(12,765,709

)

$

23,231,888

 

Net loss

 

 

—  

 

 

—  

 

 

—  

 

 

(121,665

)

 

—  

 

 

—  

 

 

(121,665

)

Other comprehensive income:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Unrealized loss on foreign currency translation, net

 

 

—  

 

 

—  

 

 

—  

 

 

—  

 

 

(37,945

)

 

—  

 

 

(37,945

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 



 

Total comprehensive loss